Harvard Bioscience, Inc. (HBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.7900 |
| Open | 2.8400 |
| Bid | 2.8700 x 100 |
| Ask | 2.9300 x 100 |
| Day's range | 2.7900 - 2.9100 |
| 52-week range | 2.6100 - 5.5600 |
| Volume | |
| Avg. volume | 133,761 |
| Market cap | 125.599M |
| Beta (5Y monthly) | 1.30 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2500 |
| Earnings date | 05 Nov 2024 - 11 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.25 |
GlobeNewswireHarvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference
HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation time of 9:15 am ET. The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website: https://investor.harvardbioscie
Simply Wall St.Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 50% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Harvard Bioscience is US$5.71 based on 2 Stage Free Cash Flow to Equity...
- Simply Wall St.
Some Analysts Just Cut Their Harvard Bioscience, Inc. (NASDAQ:HBIO) Estimates
Market forces rained on the parade of Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders today, when the analysts...
© 2024 Yahoo. All rights reserved.